Hedge Fund - Rhenman & Partners Asset Management

Henrik Rhenman Bio, Returns, AUM, Net Worth

Rhenman & Partners Asset Management is a hedge fund manager based in Stockholm, specializing in a niche strategy centered on the healthcare sector. Established in 2008 by a team of senior industry executives with extensive asset management expertise, the firm is dedicated to healthcare-focused investments.

Henrik Rhenman, Founding Partner and Chief Investment Officer at Rhenman & Partners, has been with the firm since 2008, bringing over 25 years of portfolio management experience. He holds a B.Sc. in Biochemistry from the Royal Institute of Technology and has studied at the Stockholm School of Economics.

Rhenman & Partners Asset Management reported $1,055,081,207 in managed 13F securities for Q1 2024, with a top 10 holdings concentration of 34.88%. Their largest holding is Cigna Holding Co, with 137,171 shares held.

Henrik Rhenman
Fund Profile
Filing Period:
Fund Name: Rhenman & Partners Asset Management
Manager Henrik Rhenman
Portfolio Value $902,911,938
Change This QTR +0.85%
Filing Period:
Last update:
No. Security Ticker Shares Value Activity % Port History
1. IOVA 2,502,577 $37,088,191 +47% 4.11%
2.
Astrazeneca Plc
185,000 $30,286,380 +23% 3.35%
3. MRK 206,900 $30,064,639 -4% 3.33%
4. MDT 340,000 $29,338,600 +135% 3.25%
5. UNH 71,400 $26,209,512 -24% 2.9%
News, Interviews and Investor Letters